Your browser doesn't support javascript.
loading
Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals.
Dueñas, Nuria; Navarro, Matilde; Teulé, Àlex; Solanes, Ares; Salinas, Mònica; Iglesias, Sílvia; Munté, Elisabet; Ponce, Jordi; Guardiola, Jordi; Kreisler, Esther; Carballas, Elvira; Cuadrado, Marta; Matias-Guiu, Xavier; de la Ossa, Napoleón; Lop, Joan; Lázaro, Conxi; Capellá, Gabriel; Pineda, Marta; Brunet, Joan.
Afiliação
  • Dueñas N; Hereditary Cancer Program, Catalan Institute of Oncology-IDIBELL, ONCOBELL, Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Navarro M; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Salud Carlos III, 28029 Madrid, Spain.
  • Teulé À; Hereditary Cancer Program, Catalan Institute of Oncology-IDIBELL, ONCOBELL, Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Solanes A; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Salud Carlos III, 28029 Madrid, Spain.
  • Salinas M; Hereditary Cancer Program, Catalan Institute of Oncology, Badalona, 089016 Barcelona, Spain.
  • Iglesias S; Hereditary Cancer Program, Catalan Institute of Oncology-IDIBELL, ONCOBELL, Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Munté E; Hereditary Cancer Program, Catalan Institute of Oncology, Badalona, 089016 Barcelona, Spain.
  • Ponce J; Hereditary Cancer Program, Catalan Institute of Oncology-IDIBELL, ONCOBELL, Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Guardiola J; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Salud Carlos III, 28029 Madrid, Spain.
  • Kreisler E; Hereditary Cancer Program, Catalan Institute of Oncology-IDIBELL, ONCOBELL, Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Carballas E; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto Salud Carlos III, 28029 Madrid, Spain.
  • Cuadrado M; Hereditary Cancer Program, Catalan Institute of Oncology-IDIBELL, ONCOBELL, Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Matias-Guiu X; Department of Gynecology, Bellvitge University Hospital, 08908 Hospitalet de Llobregat, 089016 Barcelona, Spain.
  • de la Ossa N; Department of Gastroenterology, Bellvitge University Hospital, Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Lop J; Department of General Surgery, Bellvitge University Hospital, Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Lázaro C; Department of Gynecology, Trias i Pujol University Hospital, Badalona, 089016 Barcelona, Spain.
  • Capellá G; Department of General Surgery, Trias i Pujol University Hospital, Badalona, 089016 Barcelona, Spain.
  • Pineda M; Department of Pathology, Bellvitge University Hospital, Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Brunet J; Department of Pathology, Trias i Pujol University Hospital, Badalona, 089016 Barcelona, Spain.
Cancers (Basel) ; 12(11)2020 Nov 18.
Article em En | MEDLINE | ID: mdl-33218006
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha